摘要
目的:探讨新生儿肺炎治疗过程中采用盐酸氨溴索雾化吸入联合超短波方法的治疗效果。方法:采集本科室自2012年8月-2013年8月收治的120例新生儿肺炎患者,分为布地奈德气雾剂治疗组,盐酸氨溴索雾化治疗组,盐酸氨溴索雾化吸入联合超短波治疗组,分别观察三组药物对新生儿肺炎的治疗效果。结果:盐酸氨溴索雾化吸入联合超短波治疗组有效率为90%,明显高于其他两组。停氧时间和住院时间较其他两组均有明显治疗优势,差异均有统计学意义(P<0.05)。结论:盐酸氨溴索雾化吸入联合超短波治疗组对治疗新生儿肺炎有着明显的治疗效果,经数据表明对吸入性肺炎以及感染性肺炎均有良好的治疗效果。
Objective：To explore the therapeutic effect of ambroxol aerosol inhalation combined with ultra-short wave in neonatal pneumonia. Method：One hundred and twenty neonatal patients with pneumonia admitted in this department from August 2012 to August 2013 were enrolled and equally divided into budesonide aerosol treatment group,ambroxol hydrochloride aerosol treatment group and ambroxol aerosol inhalation combined with ultra-short wave treatment group,and the therapeutic effects of the three treatment methods in neonatal pneumonia were evaluated. Result：The result showed that the efficient rate in ambroxol aerosol inhalation combined with ultra-short wave treatment group was 90%,which was higher than the other two groups. While clinically relevant indicators showed that the hospitalization and oxygen inhalation period were significantly shorten in ambroxol aerosol inhalation combined with ultra-short wave treatment group as compared to other two groups（P〈0.05）. Conclusion：The research data showed that ambroxol aerosol inhalation combined with ultra-short wave treatment is highly effective in the treatment of neonatal pneumonia,including aspiration pneumonia and infectious pneumonia.
出处
《中国医学创新》
CAS
2014年第8期77-79,共3页
Medical Innovation of China
